CPBTD
AZN icon

Central Pacific Bank - Trust Division’s AstraZeneca AZN Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-5,179
Closed -$982K – 861
2026
Q2 		$982K Buy
+5,179
New +$974K 0.1% 197
2026
Q1 		– Sell
-5,180
Closed -$952K – 863
2025
Q4 		$952K Buy
+5,180
New +$908K 0.12% 183
2025
Q1 		– Sell
-21
Closed -$2.75K – 850
2024
Q4 		$2.75K Hold
21
– – ﹤0.01% 787
2024
Q3 		$3.27K Hold
21
– – ﹤0.01% 766
2024
Q2 		$3.28K Hold
21
– – ﹤0.01% 844
2024
Q1 		$2.83K Buy
+21
New +$2.78K ﹤0.01% 846

Other funds holding AZN

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
CCM
Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CNBT
Canandaigua National Bank & Trust Canandaigua, New York $1.15B AUM
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Central Pacific Bank - Trust Division's AZN Position: Q3 2026 in Review

Central Pacific Bank - Trust Division sold out of AstraZeneca (AZN) in Q3 2026, closing a stake of 5,179 shares — an estimated $982K sold.

Central Pacific Bank - Trust Division first reported a position in AZN in Q1 2024 and held it in 6 quarters. The position peaked at $982K in Q2 2026. 47 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Central Pacific Bank - Trust Division reported no remaining AstraZeneca position as of Q3 2026 after selling out during the quarter.
  • Central Pacific Bank - Trust Division sold 5,179 AstraZeneca shares in Q3 2026, an estimated $982K.
  • Central Pacific Bank - Trust Division first reported a position in AstraZeneca in Q1 2024 and held it in 6 quarters.
  • Central Pacific Bank - Trust Division's AstraZeneca position peaked at $982K in Q2 2026.
  • 47 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.